Target intelligence / Profile preview

Novel transcript, antisense to KIAA1644 (null)

Target
null
Molecular classification
Long non-coding RNA (lncRNA), Natural antisense transcript (NAT)
01

Overview

LOC101927499 (ENSG00000298486, novel transcript, antisense to KIAA1644) is annotated as a long non-coding RNA gene, classified as a natural antisense transcript (NAT) overlapping the KIAA1644 locus in antisense orientation[2]. NATs are a broad class of endogenous RNA molecules with sequences complementary to other transcripts and are known, in general, to play roles in gene expression regulation, epigenetic modification, and chromatin remodeling[12][6]. However, there is currently no direct experimental evidence for the functional role, biological pathway involvement, or disease association specifically for LOC101927499[2]. It is not a known protein-coding gene, therapeutic target, receptor, enzyme, transporter, or clinically actionable locus. Its classification and annotation may be based on transcriptomics data without functional characterization[2]. This target does not meet typical criteria for a drug discovery or therapeutic target database entry, and there is no evidence of its involvement in pathophysiology or as a drug-interacting molecule.

Other names
LOC101927499ENSG00000298486novel transcript antisense to KIAA1644
02

Mechanism of action

null

03

Biological functions

Potential involvement in transcriptional regulation (general to NATs/lncRNAs, not specifically established for this locus)Epigenetic modification regulation (attributable to some NATs in general, but not demonstrated for this locus)

Beyond the preview

Go deeper on Novel transcript, antisense to KIAA1644 (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to KIAA1644 (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call